The next big disruption in the global multi-billion medical imaging market

08/02/21

Sonosine is a deep-tech company with roots in the UK science base. Today we announced our new name, Sonosine, and a fresh brand identity.

Based in Oxfordshire and formerly known as Oxford Enhanced Medical, we have a worldwide mission, to make our new type of medical imaging scanner, the Pulsar 1 accessible to all.

We have developed and patented a new and advanced medical imaging technology (EMA), that makes high-quality medical diagnostics quicker, safer and more comfortable for patients.

Sonosine’s patented Electro Magnetic Acoustic imaging (EMA) technology, embedded in our first product the Pulsar 1, is a quantum leap in medical imaging and the first significant development in this field for many years.

Celebrating our brand launch, Sonosine CEO David Herbada said that we will be working throughout 2021 to reduce the time that it takes to get to market by fostering and developing our relationships with a range of different players in the medical imaging world.

He added:

“ Sonosine’s new branding and name, signals an intention to step-up in 2021 and beyond, to take our first product, the Pulsar 1,  through commercial development, ultimately putting it into the hands of medical specialists.

We are motivated by the drive to do this because we believe that medical imaging procedures should be accessible and affordable to all, including the billion plus population in less economically privileged countries.”

Developed in 2006 at the University of Oxford by our Founder and Chief Technology Officer, Professor David Edwards, EMA uses radio signals as well as ultrasound, revealing the tissue types in areas of concern in a way that ultrasound alone cannot.

Professor Edwards said:

 Sonosine’s medical imaging product, the Pulsar 1, will put new safer, cheaper and less invasive medical imaging technology into the hands of clinicians and change the experience of medical scans for patients.

The Pulsar 1 device, currently in commercial development, will be different to all other medical imaging products on the market because it will use our patented Electro Magnetic Acoustic imaging (EMA) technology to provide high-quality images, enabling quicker, on-the-spot diagnoses and supporting improved clinical decision making. 

It will do this by increasing the amount and quality of information available to help make a diagnosis.”

 The images produced by Pulsar 1 are comparable to MRI, at the cost of an ultrasound scanner, with a very similar experience for the patient. It will enable clinicians to diagnose and treat their patients in-situ, removing the need for referrals and medical imaging escalation. It will also increase workflow efficiency in a hospital environment. 

At Sonosine, we are specialists from business, industry and academia with a common aim to contribute to human welfare around the world, including those in hard to reach communities and less developed countries. Step by step, we are doing this by introducing technology that has never been seen before to medical specialists. We know that this will dramatically improve the way that they can work with their patients. 

It is ‘onwards and upwards’ here at Sonosine, as we continue on our journey to transform medical imaging forever.

Find out more about the Pulsar 1 here .